NYSE$AHR
American Healthcare REIT Inc · Q2 2025 earnings
Q2 2025 earnings · · After market close · Investor relations
Briefing
American Healthcare REIT reported Q2 2025 revenue of $542.5M, net income of $9.9M, diluted EPS of $0.06.
For Q2 2025, American Healthcare REIT reported Revenue was $542.5M, net income was $9.9M, diluted EPS was $0.06. Management discusses segment trends, liquidity, and outlook in the quarterly filing.
- Revenue $542.5M for Q2 2025.
- Net income $9.9M.
- Diluted EPS $0.06.
Headline financials
Revenue & EPS history
American Healthcare REIT Inc · Revenue · Quarterly
$543M
Revenue by segment
American Healthcare REIT Inc · $543M total across 4 segments · Q4 2024
- ISHC$423M—78.0%
- SHOP$73.5M—13.6%
- Outpatient Medical$33.3M—6.1%
- Triple-Net Leased$12.6M—2.3%
Forward guidance
REIT outlook focuses on occupancy, rent growth, and financing costs.
Tailwinds
- Portfolio cash flows and leasing momentum.
- Development and acquisition pipelines.
Headwinds
- Interest rates and cap rates affect NAV.
- Tenant health and supply in key markets.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 11 quarterly earnings reports · overlaid with Q2 2025
+1.8%
Avg return
Earnings day
+2.2%
Avg return
5 days after
+3.9%
Avg return
30 days after
64%
7 / 11 earnings
Positive
+8.3%
Q1 2025
Best reaction
-2.1%
Q4 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2026 | — | — | — | |
| Q1 2026 | +4.3% | +4.1% | -4.2% | |
| Q4 2025 | -2.1% | -2.5% | -11.4% | |
| Q3 2025 | +3.0% | -0.1% | +4.6% | |
| Q2 2025 | +1.3% | +2.0% | +7.2% | |
| Q1 2025 | +8.3% | +6.1% | +10.2% | |
| Q4 2024 | -1.3% | +0.7% | +0.8% | |
| Q3 2024 | +1.2% | +2.7% | +7.1% | |
| Q2 2024 | +3.3% | +3.6% | +35.1% | |
| Q1 2024 | -0.1% | +3.5% | +6.2% | |
| Q2 2023 | +2.8% | +1.3% | -6.8% | |
| Q4 2023 | -0.8% | +3.2% | -5.9% | |
| Q3 2023 | — | — | — | |
| Q1 2023 | — | — | — | |
| Q4 2022 | — | — | — | |
| Q3 2022 | — | — | — | |
| Q2 2022 | — | — | — | |
| Q1 2022 | — | — | — | |
| Q4 2021 | — | — | — | |
| Q3 2021 | — | — | — | |
| Q2 2021 | — | — | — | |
| Q1 2021 | — | — | — | |
| Q4 2020 | — | — | — | |
| Q3 2020 | — | — | — | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — | |
| Q4 2019 | — | — | — | |
| Q3 2019 | — | — | — | |
| Q2 2019 | — | — | — | |
| Q1 2019 | — | — | — | |
| Q3 2018 | — | — | — | |
| Q2 2018 | — | — | — | |
| Q1 2018 | — | — | — | |
| Q3 2017 | — | — | — | |
| Q2 2017 | — | — | — | |
| Q1 2017 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro